Cytosorbents Corp
CTSO
31 hedge funds and large institutions have $7.63M invested in Cytosorbents Corp in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
150% more call options, than puts
Call options by funds: $1.3M | Put options by funds: $521K
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
15% more funds holding
Funds holding: 27 → 31 (+4)
36% less capital invested
Capital invested by funds: $11.9M → $7.63M (-$4.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
| 2 |
Morgan Stanley
New York
|
+$467K |
| 3 |
AIG
American International Group
New York
|
+$402K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$314K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$278K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$671K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$609K |
| 3 |
ACM
Aviance Capital Management
Sarasota,
Florida
|
-$568K |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$424K |
| 5 |
WCM
Wealthcare Capital Management
Richmond,
Virginia
|
-$122K |
CTSO Hedge Fund Activity: Q2 2015 in Review
31 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2015, worth a combined $7.63M — down 36% from $11.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CTSO positions and 7 closed out — a net gain of 4 holders — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.56M. The largest seller was Millennium Management, exiting entirely with an estimated $671K sold.
- 31 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2015, up from 27 in Q1 2015.
- Funds reported $7.63M of Cytosorbents Corp stock for Q2 2015, down 36% quarter-over-quarter.
- 11 funds opened new Cytosorbents Corp positions in Q2 2015 and 7 closed out, a net change of +4 holders.
- The largest Cytosorbents Corp buyer in Q2 2015 was Vanguard Group, an estimated $1.56M added.
- The largest Cytosorbents Corp seller in Q2 2015 was Millennium Management, an estimated $671K sold.
Based on aggregated 13F filings for Q2 2015.